TaiMed Biologics Inc. (TPEX:4147)
Taiwan · Delayed Price · Currency is TWD 67.40
-1.20 (-1.75%)
At close: Dec 5, 2025
TaiMed Biologics Market Cap
TaiMed Biologics has a market cap or net worth of 18.41 billion as of December 5, 2025. Its market cap has decreased by -18.25% in one year.
Market Cap
18.41B
Enterprise Value
17.15B
Revenue
607.22M
Ranking
n/a
PE Ratio
n/a
Stock Price
67.40
Market Cap Chart
Since June 28, 2010, TaiMed Biologics's market cap has increased from 2.58B to 18.41B, an increase of 613.59%. That is a compound annual growth rate of 13.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 18.41B | -21.59% |
| Dec 31, 2024 | 23.48B | 13.20% |
| Dec 29, 2023 | 20.75B | 16.27% |
| Dec 30, 2022 | 17.84B | 0.17% |
| Dec 30, 2021 | 17.81B | -16.02% |
| Dec 31, 2020 | 21.21B | -15.12% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 258.22B |
| PharmaEssentia | 191.58B |
| Lotus Pharmaceutical | 78.89B |
| Bora Pharmaceuticals Co., LTD. | 65.31B |
| Lin BioScience | 34.87B |
| Oneness Biotech | 32.96B |
| Lumosa Therapeutics | 32.77B |
| Center Laboratories | 27.88B |